These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29306481)

  • 21. Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial.
    Berwanger O; Santucci EV; de Barros E Silva PGM; Jesuíno IA; Damiani LP; Barbosa LM; Santos RHN; Laranjeira LN; Egydio FM; Borges de Oliveira JA; Dall Orto FTC; Beraldo de Andrade P; Bienert IRC; Bosso CE; Mangione JA; Polanczyk CA; Sousa AGMR; Kalil RAK; Santos LM; Sposito AC; Rech RL; Sousa ACS; Baldissera F; Nascimento BR; Giraldez RRCV; Cavalcanti AB; Pereira SB; Mattos LA; Armaganijan LV; Guimarães HP; Sousa JEMR; Alexander JH; Granger CB; Lopes RD;
    JAMA; 2018 Apr; 319(13):1331-1340. PubMed ID: 29525821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of P2Y12 reaction unit and percentage of platelet inhibition assessed by VerifyNow P2Y12 assay is a useful predictor of long-term clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Luo Y; Li J; Liu X; Xu J; Ye Z; Yao Y; Liu X; Lai Y
    Thromb Res; 2016 Mar; 139():114-20. PubMed ID: 26916306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of clinical outcomes in patients presenting with an acute coronary syndrome due to stent thrombosis or saphenous vein graft occlusion and undergoing percutaneous coronary intervention.
    Ota H; Mahmoudi M; Lhermusier T; Magalhaes MA; Torguson R; Satler LF; Suddath WO; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2015 Dec; 16(8):441-6. PubMed ID: 26704310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of 25(OH)D3 on spontaneous reperfusion and SYNTAX score in patients with ST-elevation myocardial infarction.
    Akkuş O; Topuz M; Öz F; Harbalıoğlu H; Koca H; Kaplan M; Şen Ö; Bulut A; Gür M
    Turk Kardiyol Dern Ars; 2018 Jun; 46(4):268-275. PubMed ID: 29853694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults.
    Vaes AMM; Tieland M; de Regt MF; Wittwer J; van Loon LJC; de Groot LCPGM
    Clin Nutr; 2018 Jun; 37(3):808-814. PubMed ID: 28433267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 25(OH)D3-enriched or fortified foods are more efficient at tackling inadequate vitamin D status than vitamin D3.
    Guo J; Lovegrove JA; Givens DI
    Proc Nutr Soc; 2018 Aug; 77(3):282-291. PubMed ID: 29173203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.
    Vranckx P; Frigoli E; Rothenbühler M; Tomassini F; Garducci S; Andò G; Picchi A; Sganzerla P; Paggi A; Ugo F; Ausiello A; Sardella G; Franco N; Nazzaro M; de Cesare N; Tosi P; Falcone C; Vigna C; Mazzarotto P; Di Lorenzo E; Moretti C; Campo G; Penzo C; Pasquetto G; Heg D; Jüni P; Windecker S; Valgimigli M;
    Eur Heart J; 2017 Apr; 38(14):1069-1080. PubMed ID: 28329389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic value of admission red cell distribution width-to-platelet ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Pusuroglu H; Cakmak HA; Akgul O; Erturk M; Surgit O; Akkaya E; Bulut U; Yildirim A
    Rev Port Cardiol; 2015 Oct; 34(10):597-606. PubMed ID: 26387826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosuvastatin-induced high-density lipoprotein changes in patients who underwent percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.
    Yun KH; Shin SN; Ko JS; Rhee SJ; Kim NH; Oh SK; Jeong JW
    J Cardiol; 2012 Nov; 60(5):383-8. PubMed ID: 22884684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and impact of acute kidney injury in patients with acute coronary syndromes treated with coronary artery bypass grafting: Insights from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trials.
    Warren J; Mehran R; Baber U; Xu K; Giacoppo D; Gersh BJ; Guagliumi G; Witzenbichler B; Magnus Ohman E; Pocock SJ; Stone GW
    Am Heart J; 2016 Jan; 171(1):40-7. PubMed ID: 26699599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Baseline Thrombocytopenia on Ischemic Outcomes in Patients With Acute Coronary Syndromes Who Undergo Percutaneous Coronary Intervention.
    Yadav M; Généreux P; Giustino G; Madhavan MV; Brener SJ; Mintz G; Caixeta A; Xu K; Mehran R; Stone GW
    Can J Cardiol; 2016 Feb; 32(2):226-33. PubMed ID: 26341303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The predictive value of plasma cystatin C for non-ST-elevation acute coronary syndrome treated with percutaneous coronary intervention].
    Yan S; Zhang X; Tian X; Li J; Zhuang L; Zhang X; Jiang Y
    Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(1):10-3. PubMed ID: 24721298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of vitamin D supplementation on cardiovascular risk in patients with prediabetes: A secondary analysis of the D2d study.
    Desouza C; Chatterjee R; Vickery EM; Nelson J; Johnson KC; Kashyap SR; Lewis MR; Margolis K; Pratley R; Rasouli N; Sheehan PR; Pittas AG;
    J Diabetes Complications; 2022 Aug; 36(8):108230. PubMed ID: 35753926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of multivessel percutaneous coronary intervention and coronary artery bypass grafting in patients with severe coronary artery disease presenting with non-ST-segment elevation acute coronary syndromes.
    Desperak P; Hawranek M; Hrapkowicz T; Zembala MO; Gąsior M
    Kardiol Pol; 2018; 76(10):1474-1481. PubMed ID: 30251246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender is Not a Predictor of Mortality or Major Adverse Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes.
    Josiah A; Farshid A
    Heart Lung Circ; 2019 May; 28(5):727-734. PubMed ID: 29705386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.
    Hahn JY; Song YB; Oh JH; Cho DK; Lee JB; Doh JH; Kim SH; Jeong JO; Bae JH; Kim BO; Cho JH; Suh IW; Kim DI; Park HK; Park JS; Choi WG; Lee WS; Kim J; Choi KH; Park TK; Lee JM; Yang JH; Choi JH; Choi SH; Gwon HC;
    Lancet; 2018 Mar; 391(10127):1274-1284. PubMed ID: 29544699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial.
    Mennuni MG; Dangas GD; Mehran R; Ben-Gal Y; Xu K; Généreux P; Brener SJ; Feit F; Lincoff AM; Ohman EM; Hamon M; Stone GW
    J Invasive Cardiol; 2015 Oct; 27(10):468-73. PubMed ID: 26121708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Prognosis of Deferred Acute Coronary Syndrome Lesions Based on Nonischemic Fractional Flow Reserve.
    Hakeem A; Edupuganti MM; Almomani A; Pothineni NV; Payne J; Abualsuod AM; Bhatti S; Ahmed Z; Uretsky BF
    J Am Coll Cardiol; 2016 Sep; 68(11):1181-1191. PubMed ID: 27609680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.